Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, N-Methyl-D-Aspartate | 16 | 2018 | 137 | 1.640 |
Why?
|
| Excitatory Postsynaptic Potentials | 4 | 2021 | 79 | 1.460 |
Why?
|
| Status Epilepticus | 2 | 2021 | 12 | 1.390 |
Why?
|
| Pilocarpine | 3 | 2021 | 8 | 0.910 |
Why?
|
| Receptors, Kainic Acid | 5 | 2010 | 11 | 0.880 |
Why?
|
| Hippocampus | 11 | 2018 | 561 | 0.870 |
Why?
|
| Receptors, AMPA | 5 | 2014 | 56 | 0.820 |
Why?
|
| Synaptic Transmission | 2 | 2021 | 146 | 0.810 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2021 | 34 | 0.760 |
Why?
|
| Epilepsy | 1 | 2021 | 43 | 0.750 |
Why?
|
| Glycine | 11 | 2002 | 47 | 0.700 |
Why?
|
| Disease Progression | 1 | 2021 | 601 | 0.640 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 17 | 0.620 |
Why?
|
| Excitatory Amino Acid Agonists | 5 | 2012 | 48 | 0.610 |
Why?
|
| Excitatory Amino Acid Agents | 2 | 2014 | 6 | 0.590 |
Why?
|
| Neurons | 15 | 2023 | 1175 | 0.560 |
Why?
|
| Sodium Channels | 5 | 2010 | 67 | 0.520 |
Why?
|
| Protein Subunits | 4 | 2012 | 87 | 0.520 |
Why?
|
| Oocytes | 7 | 2010 | 146 | 0.510 |
Why?
|
| Patch-Clamp Techniques | 11 | 2014 | 223 | 0.510 |
Why?
|
| Animals | 41 | 2023 | 15081 | 0.460 |
Why?
|
| Glutamic Acid | 4 | 2009 | 128 | 0.460 |
Why?
|
| Amino Acids, Cyclic | 2 | 2002 | 5 | 0.390 |
Why?
|
| Rats | 20 | 2021 | 3483 | 0.380 |
Why?
|
| Membrane Potentials | 6 | 2014 | 223 | 0.380 |
Why?
|
| Neuronal Plasticity | 3 | 2018 | 103 | 0.370 |
Why?
|
| Receptors, Muscarinic | 1 | 2010 | 18 | 0.370 |
Why?
|
| Binding Sites | 9 | 2014 | 651 | 0.370 |
Why?
|
| Muscarinic Agonists | 2 | 2021 | 10 | 0.350 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2021 | 1618 | 0.350 |
Why?
|
| Kinetics | 11 | 2014 | 708 | 0.340 |
Why?
|
| Scorpion Venoms | 4 | 2010 | 8 | 0.290 |
Why?
|
| Amino Acids | 2 | 1999 | 145 | 0.270 |
Why?
|
| Acidosis | 1 | 2005 | 51 | 0.240 |
Why?
|
| Long-Term Potentiation | 2 | 2017 | 102 | 0.230 |
Why?
|
| Glutamates | 3 | 2001 | 22 | 0.230 |
Why?
|
| Cells, Cultured | 11 | 2018 | 1518 | 0.230 |
Why?
|
| Arginine Vasopressin | 1 | 2023 | 13 | 0.220 |
Why?
|
| Mice | 17 | 2023 | 5913 | 0.220 |
Why?
|
| Neuroprotective Agents | 2 | 2005 | 245 | 0.220 |
Why?
|
| Eye Movements | 1 | 2022 | 14 | 0.220 |
Why?
|
| Brain Ischemia | 1 | 2005 | 184 | 0.210 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2023 | 43 | 0.210 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 2 | 2014 | 9 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2010 | 1039 | 0.210 |
Why?
|
| Calcium Channels, N-Type | 2 | 2014 | 6 | 0.210 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 360 | 0.210 |
Why?
|
| Cations | 1 | 2002 | 45 | 0.210 |
Why?
|
| Cycloserine | 1 | 2001 | 3 | 0.200 |
Why?
|
| Antimetabolites | 1 | 2001 | 5 | 0.200 |
Why?
|
| Transfection | 6 | 2014 | 523 | 0.200 |
Why?
|
| Mutation | 4 | 2014 | 1095 | 0.200 |
Why?
|
| N-Methylaspartate | 5 | 2002 | 57 | 0.190 |
Why?
|
| Xenopus | 5 | 2010 | 48 | 0.190 |
Why?
|
| Membrane Proteins | 1 | 2005 | 517 | 0.190 |
Why?
|
| Circadian Rhythm | 1 | 2023 | 225 | 0.180 |
Why?
|
| 2-Amino-5-phosphonovalerate | 4 | 1992 | 6 | 0.180 |
Why?
|
| Ion Channel Gating | 3 | 2010 | 83 | 0.180 |
Why?
|
| Electric Stimulation | 2 | 2017 | 184 | 0.170 |
Why?
|
| Chronic Disease | 2 | 2021 | 484 | 0.170 |
Why?
|
| Endocytosis | 3 | 1990 | 113 | 0.160 |
Why?
|
| Action Potentials | 3 | 2017 | 231 | 0.160 |
Why?
|
| Xenopus laevis | 3 | 2009 | 73 | 0.160 |
Why?
|
| Point Mutation | 2 | 2018 | 93 | 0.150 |
Why?
|
| Models, Biological | 4 | 2014 | 677 | 0.150 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2018 | 77 | 0.150 |
Why?
|
| Calcium | 5 | 2014 | 480 | 0.150 |
Why?
|
| Oxazines | 2 | 2014 | 26 | 0.140 |
Why?
|
| Spermine | 2 | 1997 | 64 | 0.140 |
Why?
|
| Stress, Psychological | 1 | 2022 | 583 | 0.140 |
Why?
|
| Brain | 4 | 2013 | 1346 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 190 | 0.140 |
Why?
|
| Electrophysiology | 7 | 2004 | 136 | 0.130 |
Why?
|
| Excitatory Amino Acid Antagonists | 3 | 2002 | 99 | 0.130 |
Why?
|
| Computer Simulation | 2 | 2014 | 362 | 0.130 |
Why?
|
| Benzothiadiazines | 1 | 2014 | 3 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 5 | 2022 | 1609 | 0.120 |
Why?
|
| Ion Channels | 2 | 2011 | 71 | 0.120 |
Why?
|
| Protein Binding | 5 | 2014 | 972 | 0.120 |
Why?
|
| Migraine with Aura | 1 | 2014 | 1 | 0.120 |
Why?
|
| Quinones | 1 | 2014 | 14 | 0.120 |
Why?
|
| Nerve Net | 3 | 2003 | 76 | 0.110 |
Why?
|
| Calcium Channels | 1 | 2014 | 76 | 0.110 |
Why?
|
| Sleep Deprivation | 1 | 2013 | 26 | 0.110 |
Why?
|
| Drug Discovery | 1 | 2014 | 82 | 0.110 |
Why?
|
| Pipecolic Acids | 1 | 1992 | 7 | 0.110 |
Why?
|
| Propionates | 1 | 1992 | 26 | 0.110 |
Why?
|
| Electroencephalography | 1 | 2013 | 116 | 0.110 |
Why?
|
| Nootropic Agents | 1 | 2012 | 7 | 0.110 |
Why?
|
| Acetamides | 1 | 2012 | 11 | 0.110 |
Why?
|
| Biphenyl Compounds | 1 | 1992 | 53 | 0.110 |
Why?
|
| Epidermal Growth Factor | 2 | 1989 | 68 | 0.100 |
Why?
|
| Models, Molecular | 2 | 2014 | 808 | 0.100 |
Why?
|
| Thiophenes | 1 | 2012 | 31 | 0.100 |
Why?
|
| Pyrazoles | 1 | 2012 | 85 | 0.100 |
Why?
|
| Male | 7 | 2022 | 20025 | 0.100 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 59 | 0.090 |
Why?
|
| Sodium Channel Blockers | 1 | 2010 | 17 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 142 | 0.090 |
Why?
|
| Aspartic Acid | 1 | 1990 | 47 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 132 | 0.090 |
Why?
|
| Markov Chains | 1 | 2009 | 35 | 0.090 |
Why?
|
| Parvalbumins | 1 | 2009 | 16 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2008 | 364 | 0.090 |
Why?
|
| Purkinje Cells | 1 | 2009 | 20 | 0.090 |
Why?
|
| Protein Conformation | 3 | 2012 | 389 | 0.090 |
Why?
|
| Cell Death | 1 | 2010 | 267 | 0.080 |
Why?
|
| Synapses | 2 | 2008 | 180 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 290 | 0.080 |
Why?
|
| Mossy Fibers, Hippocampal | 1 | 2008 | 10 | 0.080 |
Why?
|
| Zinc | 2 | 2008 | 128 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 1371 | 0.080 |
Why?
|
| Models, Theoretical | 2 | 2014 | 217 | 0.080 |
Why?
|
| Muscle Proteins | 1 | 2007 | 51 | 0.070 |
Why?
|
| Shab Potassium Channels | 1 | 2007 | 2 | 0.070 |
Why?
|
| Qa-SNARE Proteins | 1 | 2007 | 9 | 0.070 |
Why?
|
| Secretory Vesicles | 1 | 2007 | 20 | 0.070 |
Why?
|
| Mice, Inbred Strains | 4 | 2009 | 116 | 0.070 |
Why?
|
| Structure-Activity Relationship | 4 | 2012 | 409 | 0.070 |
Why?
|
| Exocytosis | 1 | 2007 | 47 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2012 | 295 | 0.070 |
Why?
|
| Analgesics | 1 | 2007 | 54 | 0.070 |
Why?
|
| Mammals | 2 | 2022 | 105 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 282 | 0.060 |
Why?
|
| Humans | 12 | 2014 | 37093 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2005 | 107 | 0.060 |
Why?
|
| Sodium | 2 | 2002 | 103 | 0.060 |
Why?
|
| Pain | 1 | 2007 | 251 | 0.060 |
Why?
|
| Cell Line | 5 | 2009 | 1354 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2005 | 101 | 0.060 |
Why?
|
| Binding, Competitive | 3 | 1992 | 111 | 0.060 |
Why?
|
| Allosteric Site | 2 | 2014 | 11 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2001 | 343 | 0.060 |
Why?
|
| Magnesium | 2 | 2002 | 97 | 0.060 |
Why?
|
| Rats, Wistar | 3 | 2010 | 233 | 0.050 |
Why?
|
| Biophysical Phenomena | 2 | 2014 | 22 | 0.050 |
Why?
|
| Scorpions | 3 | 2010 | 7 | 0.050 |
Why?
|
| Kynurenic Acid | 3 | 1991 | 9 | 0.050 |
Why?
|
| Biophysics | 2 | 2014 | 37 | 0.050 |
Why?
|
| Arginine | 1 | 2023 | 73 | 0.050 |
Why?
|
| Ion Transport | 1 | 2002 | 17 | 0.050 |
Why?
|
| Cerebellum | 2 | 1999 | 73 | 0.050 |
Why?
|
| Cell Membrane Permeability | 1 | 2002 | 52 | 0.050 |
Why?
|
| Ligands | 2 | 2014 | 349 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 408 | 0.050 |
Why?
|
| Female | 3 | 2010 | 20969 | 0.050 |
Why?
|
| Perfusion | 1 | 2001 | 33 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2002 | 212 | 0.050 |
Why?
|
| Receptors, Neurotransmitter | 3 | 2007 | 21 | 0.050 |
Why?
|
| Stroke | 1 | 2005 | 286 | 0.050 |
Why?
|
| Prefrontal Cortex | 1 | 2022 | 137 | 0.050 |
Why?
|
| Sleep | 1 | 2022 | 152 | 0.050 |
Why?
|
| Cysteine | 1 | 2001 | 98 | 0.050 |
Why?
|
| Alanine | 2 | 1990 | 30 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 208 | 0.040 |
Why?
|
| Piperazines | 2 | 1991 | 111 | 0.040 |
Why?
|
| Models, Chemical | 1 | 2001 | 207 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2007 | 1180 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2007 | 1568 | 0.040 |
Why?
|
| Protein Structure, Secondary | 2 | 2011 | 183 | 0.040 |
Why?
|
| CHO Cells | 2 | 2010 | 124 | 0.040 |
Why?
|
| Conditioning, Classical | 1 | 2018 | 61 | 0.040 |
Why?
|
| Cricetinae | 2 | 2010 | 238 | 0.040 |
Why?
|
| Cell Membrane | 2 | 1989 | 381 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 169 | 0.030 |
Why?
|
| Ibogaine | 1 | 1995 | 2 | 0.030 |
Why?
|
| Models, Neurological | 2 | 2000 | 128 | 0.030 |
Why?
|
| Intracellular Fluid | 1 | 2014 | 26 | 0.030 |
Why?
|
| Kidney | 2 | 2012 | 337 | 0.030 |
Why?
|
| Neuromuscular Junction | 1 | 2014 | 33 | 0.030 |
Why?
|
| Wakefulness | 1 | 2013 | 21 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2014 | 99 | 0.030 |
Why?
|
| Serine | 1 | 2014 | 75 | 0.030 |
Why?
|
| Electromyography | 1 | 2013 | 55 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2004 | 269 | 0.030 |
Why?
|
| Lysine | 1 | 2014 | 113 | 0.030 |
Why?
|
| Drosophila | 1 | 2014 | 144 | 0.030 |
Why?
|
| Drug Synergism | 1 | 1993 | 177 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2012 | 48 | 0.030 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2012 | 71 | 0.030 |
Why?
|
| Homeostasis | 1 | 2013 | 188 | 0.030 |
Why?
|
| Benzamides | 1 | 2012 | 78 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2012 | 80 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2011 | 22 | 0.020 |
Why?
|
| Membrane Fluidity | 2 | 1988 | 11 | 0.020 |
Why?
|
| Diffusion | 2 | 1988 | 50 | 0.020 |
Why?
|
| Culture Media | 1 | 2011 | 90 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 1991 | 152 | 0.020 |
Why?
|
| Drug Design | 1 | 2012 | 162 | 0.020 |
Why?
|
| Homoserine | 1 | 1990 | 1 | 0.020 |
Why?
|
| Ricin | 1 | 1990 | 3 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 265 | 0.020 |
Why?
|
| Bites and Stings | 1 | 2010 | 11 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1990 | 58 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 80 | 0.020 |
Why?
|
| Organelles | 1 | 1989 | 24 | 0.020 |
Why?
|
| Periodicity | 1 | 2009 | 34 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 893 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1989 | 252 | 0.020 |
Why?
|
| Coated Pits, Cell-Membrane | 1 | 1988 | 3 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 80 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 1995 | 730 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2011 | 587 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2008 | 57 | 0.020 |
Why?
|
| Neurotransmitter Transport Proteins | 1 | 2007 | 2 | 0.020 |
Why?
|
| Desipramine | 1 | 2007 | 10 | 0.020 |
Why?
|
| Microdialysis | 1 | 2007 | 18 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2007 | 28 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 36 | 0.020 |
Why?
|
| Pain Threshold | 1 | 2007 | 28 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2007 | 93 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2007 | 89 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2007 | 110 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 131 | 0.020 |
Why?
|
| Electric Conductivity | 2 | 1997 | 51 | 0.020 |
Why?
|
| Acute Disease | 1 | 2007 | 147 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2009 | 933 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2007 | 59 | 0.020 |
Why?
|
| Reaction Time | 1 | 2007 | 143 | 0.020 |
Why?
|
| Serotonin | 1 | 2007 | 123 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1986 | 100 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1986 | 144 | 0.020 |
Why?
|
| Dopamine | 1 | 2007 | 245 | 0.020 |
Why?
|
| Synaptosomes | 1 | 2004 | 21 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2004 | 62 | 0.020 |
Why?
|
| Motor Activity | 1 | 2007 | 418 | 0.010 |
Why?
|
| Floxuridine | 1 | 2003 | 3 | 0.010 |
Why?
|
| Neural Conduction | 1 | 2003 | 17 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 2003 | 22 | 0.010 |
Why?
|
| Dendrites | 1 | 2003 | 55 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1997 | 167 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 191 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2003 | 265 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 325 | 0.010 |
Why?
|
| Axons | 1 | 2003 | 108 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 307 | 0.010 |
Why?
|
| Neuroglia | 1 | 2003 | 124 | 0.010 |
Why?
|
| Electrodes | 1 | 2002 | 45 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2004 | 453 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 515 | 0.010 |
Why?
|
| DNA | 1 | 2004 | 574 | 0.010 |
Why?
|
| Ions | 1 | 2001 | 61 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 997 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2001 | 180 | 0.010 |
Why?
|
| Algorithms | 1 | 2000 | 465 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 1742 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1995 | 66 | 0.010 |
Why?
|
| Dizocilpine Maleate | 1 | 1995 | 48 | 0.010 |
Why?
|
| Naloxone | 1 | 1995 | 52 | 0.010 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1995 | 107 | 0.010 |
Why?
|
| Anesthetics | 1 | 1992 | 11 | 0.010 |
Why?
|
| Polyamines | 1 | 1992 | 30 | 0.010 |
Why?
|
| Receptors, Glutamate | 1 | 1990 | 27 | 0.010 |
Why?
|
| Hemagglutination Tests | 1 | 1990 | 3 | 0.010 |
Why?
|
| Thiocyanates | 1 | 1990 | 7 | 0.010 |
Why?
|
| Fluoresceins | 1 | 1990 | 27 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1990 | 22 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1990 | 23 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1990 | 96 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 201 | 0.010 |
Why?
|
| Biological Transport | 1 | 1990 | 185 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1990 | 181 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1990 | 502 | 0.010 |
Why?
|
| Cell Survival | 1 | 1990 | 864 | 0.000 |
Why?
|
| Genetic Engineering | 1 | 1986 | 33 | 0.000 |
Why?
|
| Chromosome Deletion | 1 | 1986 | 56 | 0.000 |
Why?
|